These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33567877)

  • 1. Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
    Vergès B; Pignol E; Rouland A; Bouillet B; Baillot-Rudoni S; Quilot E; Djeffal A; Petit JM
    J Diabetes Sci Technol; 2022 Jul; 16(4):982-987. PubMed ID: 33567877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria, glycemic variability and effect of flash glucose monitoring based decision making on short term glycemic variability in Indian type 2 diabetes patients: Indi-GlyVar study.
    Nathiya D; Singh M; Suman S; Bareth H; Pal N; Jain A; Tomar BS
    Front Endocrinol (Lausanne); 2022; 13():1011411. PubMed ID: 36465630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term glycemic variability in non-diabetic, non-obese dogs assessed by common glycemic variability indices.
    Urbanschitz T; Huber L; Tichy A; Burgener IA; Zeugswetter FK
    Res Vet Sci; 2024 Mar; 169():105156. PubMed ID: 38340380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.
    Marling CR; Shubrook JH; Vernier SJ; Wiley MT; Schwartz FL
    J Diabetes Sci Technol; 2011 Jul; 5(4):871-8. PubMed ID: 21880228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Glycemic Variability Evaluated by Continuous Glucose Monitoring is Associated with Osteoporosis in Type 2 Diabetic Patients.
    Huang R; Wang H; Shen Z; Cai T; Zhou Y; Wang Y; Xia W; Ding B; Yan R; Li H; Wu J; Ma J
    Front Endocrinol (Lausanne); 2022; 13():861131. PubMed ID: 35733774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control.
    Rodbard D
    Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S55-67. PubMed ID: 19469679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with nocturnal and diurnal glycemic variability in patients with type 2 diabetes: a cross-sectional study.
    Jiang J; Xia Z; Zheng D; Li Y; Li F; Wang W; Ding S; Zhang J; Su X; Zhai Q; Zuo Y; Zhang Y; Gaisano HY; He Y; Sun J
    J Endocrinol Invest; 2024 Jan; 47(1):245-253. PubMed ID: 37354249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.
    Breyton AE; Lambert-Porcheron S; Laville M; Vinoy S; Nazare JA
    Front Endocrinol (Lausanne); 2021; 12():666008. PubMed ID: 34566883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm.
    Baghurst PA
    Diabetes Technol Ther; 2011 Mar; 13(3):296-302. PubMed ID: 21291334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean amplitude of glycemic excursions in septic patients and its association with outcomes: A prospective observational study using continuous glucose monitoring.
    Furushima N; Egi M; Obata N; Sato H; Mizobuchi S
    J Crit Care; 2021 Jun; 63():218-222. PubMed ID: 32958351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Glycemic Variability During a Diabetes Self-Management Educational Program.
    Joshi A; Mitra A; Anjum N; Shrivastava N; Khadanga S; Pakhare A; Joshi R
    Med Sci (Basel); 2019 Mar; 7(3):. PubMed ID: 30934620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
    Ohara M; Hiromura M; Nagaike H; Kohata Y; Fujikawa T; Goto S; Sato N; Kushima H; Terasaki M; Yamamoto T; Mori Y; Hayashi T; Fukui T; Yamagishi SI; Hirano T
    Diabetes Res Clin Pract; 2019 Dec; 158():107904. PubMed ID: 31672500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.
    Nakata K; Miki T; Tanno M; Ohnishi H; Yano T; Muranaka A; Sato T; Oshima H; Tatekoshi Y; Mizuno M; Abe K; Miura T
    PLoS One; 2017; 12(12):e0188689. PubMed ID: 29261679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of early glycemic variability on mortality and neurologic outcome of very low birth weight infants: Data from a continuous glucose monitoring system.
    Jagła M; Szymońska I; Starzec K; Kwinta P
    Dev Period Med; 2019; 23(1):7-14. PubMed ID: 30954975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of average daily risk range scores for young children with type 1 diabetes mellitus using continuous glucose monitoring and self-monitoring data.
    Patton SR; Midyett LK; Dolan LM; Powers SW
    Diabetes Technol Ther; 2012 Mar; 14(3):239-43. PubMed ID: 22047051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Variability: A Review of Clinical Applications and Research Developments.
    Rodbard D
    Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycemic variability on short term prognosis in acute myocardial infarction subjects undergoing primary percutaneous coronary interventions.
    Zhang JW; He LJ; Cao SJ; Yang Q; Yang SW; Zhou YJ
    Diabetol Metab Syndr; 2014; 6():76. PubMed ID: 25013458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.
    Oe Y; Nomoto H; Nakamura A; Kuwabara S; Takahashi Y; Yasui A; Izumihara R; Miya A; Kameda H; Cho KY; Atsumi T; Miyoshi H
    J Diabetes Res; 2022; 2022():5603864. PubMed ID: 35097130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coefficient of variation of R-R interval closely correlates with glycemic variability assessed by continuous glucose monitoring in insulin-depleted patients with type 1 diabetes.
    Iwasaki S; Kozawa J; Fukui K; Iwahashi H; Imagawa A; Shimomura I
    Diabetes Res Clin Pract; 2015 Aug; 109(2):397-403. PubMed ID: 26047681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.